Overview

Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if denosumab is effective in the treatment of relapsed or plateau-phase multiple myeloma.
Phase:
Phase 2
Details
Lead Sponsor:
Amgen
Treatments:
Denosumab